Related Experiment Video
Updated: Oct 5, 2025

Non-enzymatic, Serum-free Tissue Culture of Pre-invasive Breast Lesions for Spontaneous Generation of Mammospheres
Published on: November 8, 2014
Solid papillary carcinoma of the breast
Toyaja Jadhav1, Shashi Shekhar Prasad1, Bhupesh Guleria2
1Command Hospital (Southern Command), Department of Pathology, Pune, Maharashtra, India.
Solid Papillary Carcinoma (SPC) of the breast is a rare, low-grade tumor primarily affecting older women. Immunohistochemistry aids in differentiating SPC from mimics, crucial for accurate diagnosis and favorable prognosis.
Area of Science:
- Oncology
- Pathology
- Breast Cancer Research
Background:
- Solid Papillary Carcinoma (SPC) is a rare breast tumor (<1% incidence), predominantly in postmenopausal women.
- Characterized by well-defined nodules, low-grade nuclei, fibrovascular cores, and neuroendocrine differentiation.
- Often misdiagnosed due to morphological similarities with pre-malignant conditions.
Purpose of the Study:
- To present a case of SPC with a focus of invasion.
- To review the literature on SPC diagnosis and management.
- To highlight the importance of immunohistochemistry in differentiating SPC from mimics.
Main Methods:
- Case presentation of a patient with SPC.
- Literature review focusing on diagnostic challenges and immunohistochemical markers.
- Morphological and immunohistochemical analysis.
Main Results:
- The presented case demonstrates SPC with a minor invasive component.
- Immunohistochemistry is vital for distinguishing SPC from other breast lesions.
- SPC generally exhibits a favorable prognosis.
Conclusions:
- Accurate diagnosis of SPC is essential for appropriate patient management.
- Immunohistochemical panels are critical for resolving diagnostic ambiguities.
- SPC, despite mimicry, offers a good prognosis when correctly identified.
More Related Videos
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
Published on: December 19, 2019
07:08Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024